Detection of Epstein-Barr Virus DNA in sera from transplant recipients with lymphoproliferative disorders

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 1113-1116

  Limaye, Ajit P ^a,c   Huang, Meei Li ^b   Atienza, Ederlyn E ^b   Ferrenberg, James M ^b   Corey, Lawrence ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA PURIFICATION; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

DNA VIRUSES; HUMAN HERPESVIRUS 4; MARTES PENNANTI;

EID: 0033026529     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.1113-1116.1999     Document Type: Article

References (29)

1. Baer, R., A. T. Bankier, M. D. Biggen, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
2. Bai, X., G. Hosler, B. B. Rogers, D. B. Dawson, and R. H. Scherermann. 1997. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin. Chem. 43:1843-1849.
3. Barkholt, L. M., H. Dahl, M. Enbom, and A. Linde. 1996. Epstein-Barr virus DNA in serum after liver transplantation - surveillance of viral activity during treatment with different immunosuppressive agents. Transplant. Int. 9: 439-445.
4. Chang, K. L., Y. Y. Chen, D. Shibata, and L. M. Weiss. 1992. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1:246-255.
5. Cherqui, D., C. Duvoux, F. Plassa, P. Gaulard, M. Julien, P. L. Fagniez, D. Dhumearx, M. Goossens, and J. P. Farcet. 1993. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 56:1023-1026.
6. Cone, R. W., A. C. Hobson, and M.-L. W. Huang. 1992. Coamplified positive control detects inhibition of polymerase chain reactions. J. Clin. Microbiol. 30:3185-3189.
7. Craig, F. E., M. L. Galley, and P. M. Banks. 1993. Posttransplantation lymphoproliferative disorders. Am. J. Clin. Pathol. 99:265.
8. Fontan, J., A. Bassignot, C. Mougin, J. Y. Cahn, and M. Lab. 1998. Detection of Epstein-Barr virus DNA in serum of transplanted patients: a new diagnostic guide for lymphoproliferative diseases. Leukemia 12:772.
9. Green, M., J. Reyes, N. Jabbour, E. Yunis, P. Putnam, S. Todo, and D. Rowe. 1996. Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant. Proc. 28:2759-2760.
10. Kenagy, D. N., Y. Schlesinger, K. Weck, J. N. Ritter, M. M. Gaudreault-Keener, and G. A. Storch. 1995. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 60:547-554.
11. Khanna, R., S. R. Burrows, and D. J. Moss. 1995. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59:387-405.
12. Koelle, D. M., M. L. Huang, B. Chandran, J. Vieira, M. Piepkorn, and L. Corey. 1997. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J. Infect. Dis. 176:94-102.
13. Lager, D. J., H. Burgart, and D. D. Slagel. 1993. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder. Mod. Pathol. 6:42-46.
14. Lucas, K. G., R. L. Burton, S. E. Zimmerman, J. Wang, K. G. Cornetta, K. A. Robertson, C. H. Lee, and D. J. Emmanuel. 1998. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654-3661.
15. Martinez, O. M., J. C. Villanueva, L. Lawrence-Miyasaki, M. B. Quinn, K. Cox, and S. M. Krams. 1995. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation 59: 519-524.
16. Nalesnik, M. A., R. Jaffe, T. E. Starzl, A. J. Demetris, K. Porter, J. A. Burnham, L. Makowka, M. Ho, and J. Locker. 1988. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am. J. Pathol. 133:173-192.
17. Preiksaitis, J. K., F. Diaz-Mitoma, F. Mirzayans, S. Roberts, and D. H. Tyrrell. 1992. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients; relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J. Infect. Dis. 166:986-994.
18. Purtilo, D. T. 1981. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. Adv. Cancer Res. 34:279.
19. Randhawa, P. S., R. Jaffee, M. Demetris, M. Nalesnik, T. E. Starzl, Y. Y. Chen, and L. M. Weiss. 1991. The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am. J. Pathol. 138:1027-1033.
20. Randhawa, P. S., R. Jaffe, A. J. Demetris, M. Nalesnik, T. E. Starzl, Y. Y. Chen, and L. M. Weiss. 1992. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N. Engl. J. Med. 327:1710-1714.
21. Randhawa, P. S., S. A. Yousem, I. L. Paradis, J. A. Dauber, B. P. Griffith, and J. Locker. 1989. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am. J. Clin. Pathol. 92:177-185.
22. Riddler, S. A., M. C. Breinig, and J. L. C. McKnight. 1994. Increased levels of circulating Epstein-Barr-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972-984.
23. Rooney, C. M., S. K. Loftin, M. S. Holladay, M. K. Brenner, R. A. Krance, and H. E. Heslop. 1995. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br. J. Haematol. 89:98-103.
24. Rowe, D. T., L. Qu, J. Reyes, N. Jabbour, E. Yunis, P. Putnam, S. Todo, and M. Green. 1997. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J. Clin. Microbiol. 35:1612-1615.
25. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Affieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715-2722.
26. Starzl, T. E., K. A. Porter, S. Iwatsuki, J. T. Rosenthal, B. W. Shaw, R. W. Atchison, M. A. Nalesnik, M. Ho, B. P. Griffith, T. R. Hakala, R. L. Hardesty, and R. Jaffe. 1984. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet i:583.
27. Swerdlow, S. H. 1992. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20: 373-385.
28. Thorley-Lawson, D. A. 1988. Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. Biochim. Biophys. Acta 948:263-286.
29. Weiss, L. M., and L. A. Movahed. 1989. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am. J. Pathol. 134:651-659.